Suganob, Marites Q.
HRN: 28-32-02 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/21/2025
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
12/21/2025
12/28/2025
IV
1.5g
Q8
Cellulitis
Checking Initial Appropriateness
12/27/2025
CLINDAMYCIN 150MG/ML, 4ML (AMP)
12/27/2025
01/03/2026
IVT
600mg
Q8
Cellulitis Right Foot
Checking Initial Appropriateness